In January, CareYaya was among a dozen companies named to the third CancerX Accelerator Cohort for “developing solutions to help transform how cancer is prevented, diagnosed, and treated.” CancerX ...

Deaf patients face major gaps in stroke care, from poor ASL health literacy to interpreter barriers, undermining discharge ...

Use of the Psychiatric Collaborative Care Model (CoCM) increased 26-fold nationally among commercially insured patients ...

Rising stroke rates in young adults highlight urgent prevention—manage blood pressure and cholesterol early, address obesity ...

Researchers at City St. George’s, University of London, have identified a new molecular signature that may explain why ...

Alteplase, a “clot-buster” medication used to treat ischemic stroke, acute myocardial infarctions, and acute pulmonary ...

Senate Democrats are advancing a new prescription drug pricing agenda they say would lower costs for patients, reduce wasteful health care spending, and strengthen US biomedical innovation, while ...

The Consolidated Appropriations Act of 2026 features new language that could change the way that pharmacy benefit managers ...

The Consolidated Appropriations Act of 2026 features new language that could change the way that pharmacy benefit managers (PBMs) operate in the US.

An independent predictor of CS-responsive MG was ptosis (OR, 2.13; 95% CI, 1.05-4.32), but this association only remained when AChR antibody–positive status was an independent predictor of CRMG (OR, 2 ...

Medicare beneficiaries whose physicians participate in accountable care organizations (ACOs), particularly those taking on financial risk for cost and quality, receive substantially more primary and ...

Margaret Krackeler, MD, of Kaiser Permanente Northern California, discusses the growing role of real-world treatment data in CLL and other cancers.